Fertin Pharma completes cross-border acquisition of Tab Labs
On Jan. 7, 2019, Fertin Pharma A/S announced that it had acquired Tab Labs Inc.
Fertin Pharma, headquartered in Vejle, Denmark, is the leading independent B2B developer and manufacturer of medicated chewing gum, primarily nicotine chewing gum used for withdrawal management in the process of tobacco cessation. Tab Labs is a full-service, private label contract manufacturer of functional tablets and chewing gum based in Vancouver, British Columbia.